Cargando…
Clinical Outcomes of COVID-19 in Common Variable Immunodeficiency Patients
Autores principales: | Nye, Derek, Kaminsky, Lauren, Al-Shaikhly, Taha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804448/ http://dx.doi.org/10.1016/j.jaci.2021.12.476 |
Ejemplares similares
-
Tixagevimab-Cilgavimab Rollout on Common Variable Immunodeficient Patients: Early Lessons from an Academic Allergy and Immunology Clinic
por: Dluzynski, Daniela, et al.
Publicado: (2023) -
Penicillin Allergy Label Increases Risk of Worse Clinical Outcomes in COVID-19
por: Kaminsky, Lauren W., et al.
Publicado: (2021) -
COVID-19 and Common Variable Immunodeficiency
por: Kaminski, Marina, et al.
Publicado: (2021) -
The Diagnosis of Common Variable Immunodeficiency After Multisystem Dysfunction
por: Rasul, Taha F, et al.
Publicado: (2022) -
The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019
por: Fill, Lauren, et al.
Publicado: (2020)